Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125611001 | 12561100 | 1 | I | 20160714 | 20160715 | 20160715 | EXP | GB-ABBVIE-16P-167-1673159-00 | GB-009507513-1607GBR006530 | MERCK | 0.00 | M | Y | 0.00000 | 20160715 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125611001 | 12561100 | 1 | PS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | UNK | U | U | 20903 | CAPSULE | |||||||
| 125611001 | 12561100 | 2 | SS | EXVIERA | DASABUVIR | 1 | Oral | UNK | U | U | 0 | TABLET | |||||||
| 125611001 | 12561100 | 3 | SS | VIEKIRAX | OMBITASVIRPARITAPREVIRRITONAVIR | 1 | Oral | UNK | U | U | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125611001 | 12561100 | 1 | Hepatitis C |
| 125611001 | 12561100 | 2 | Hepatitis C |
| 125611001 | 12561100 | 3 | Hepatitis C |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125611001 | 12561100 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125611001 | 12561100 | Blood bilirubin increased | |
| 125611001 | 12561100 | Cellulitis | |
| 125611001 | 12561100 | Hepatic failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |